Poultry Vaccines Market Overview:

The global poultry vaccines market was valued at USD 1,825 million in 2021. The market is forecast to grow at a 6.6% CAGR between 2023-2032.

These key drivers include product R&D growth, increasing incidence of diseases in poultry, the need to secure food sources, and awareness and initiatives to combat antimicrobial resistance. HIPRA launched EVANT, an attenuated broiler vaccine in 2019, to expand its coccidiosis vaccination portfolio.

Global Poultry Vaccines Market Scope:

Product analysis

With a revenue share of 32.3%, the segment attenuated vaccines accounted for the largest portion of 2021's revenues. These vaccines may trigger the immune system's production of more antibodies than other types. Additionally, these vaccines have a longer duration of immunity and are more effective in protecting against avian diseases like Newcastle disease, infectious bursal illness, and infectious bronchitis. In addition, the segment is experiencing a boom in R&D to combat various outbreaks of these diseases, especially in the vaccine field. It is expected that the recombinant and inactivated vaccine sectors will experience significant growth in the future. This growth is due to product innovations and safety benefits of inactivated and/or recombinant vaccinations in comparison with live attenuated vaccines. Zoetis has a large portfolio of vaccines available for poultry under its Poulvac name.

Request Covid - 19 Impact

Disease Type Analysis

The largest revenue share, 9.7% in 2021 was held by the Salmonella Diseases segment. Over the forecast period, the Egg Drop Syndrome(EDS) segment will grow at the fastest rate of CAGR. This is because of the high prevalence and severity of Salmonella-related diseases in poultry. The most widespread type of vaccine for salmonella is attenuated Salmonella varieties. They can be as safe as safe oral carrier vaccines against necrotic encephalitis by expressing heterologous antibodies. To increase the market, share, and market presence, market leaders are involved in R&D and the launching of new vaccines. Venkys India, a company that makes poultry vaccines, has the Salmonella polyvalent vaccine inactivated vaccine. This vaccine is used for the prevention and control of Salmonellosis in broilers, layers, and breeders. OILVAXEDS-76 is a part of KM Biologics. It is effective against eggs drop syndrome.

Application analysis

The largest revenue share, at 38.5%, was held by the breeder sector in 2021. It is expected to see significant growth over the forecast period due to the increase in breeder farms producing a fertile eggs, which are hatched by a hatchery. The growth of this market is due to the increased productivity of these breeding farms. Many government initiatives have contributed to the market growth. They have vaccinated breeders and protected the progeny. The broilers.

Pro-active government policy has largely contributed to the rise of breeder farms. These policies have seen an increase in the number and quality of poultry farmers, breeders, integrators, and feeders. India's Animal Husbandry Department increased production by implementing a comprehensive poultry development strategy. The policy was meant to promote exports by encouraging the processing of chickens and eggs, as well as an increase in production from commercial broilers. This government's positive initiative is driving the market.

Кеу Маrkеt Ѕеgmеntѕ:

By Product

• Attenuated Live Vaccines
• Subunit Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Inactivated Vaccines

By Disease Type

• Infectious Bursal Diseases
• Egg Drop Syndrome
• Infectious Bronchitis
• Adenovirus
• Duck Viral Enteritis
• Infectious Laryngotracheitis
• Others

By Application

• Layer
• Breeder
• Broiler

Market Dynamics:

The COVID-19 Pandemic negatively impacted the poultry sector with low demand, low supplies, and a fall in poultry meat and egg prices. India, a country with a large poultry population, was particularly affected. Although essential services were provided for egg, dairy, and meat productions, the lockdowns and movement restrictions caused disruptions in the supply chain. These challenges, together with the fear and emergence of other avian illnesses such as Bird flu from India, only exacerbated its negative impact. However, the COVID-19 outbreak has provided opportunities for vaccine manufacturers to grow their market share. The market leader Venkys India is involved in SPF eggs, broiler & layer breeding, chicken & eggs processing, poultry feed & equipment, vaccine manufacturing, biosecurity products, and many other areas. The company has a broad portfolio of poultry vaccinations. These, along with other poultry products made up 45% of the company's 2019 revenue.

The rising number of avian illnesses and the expanding poultry population will drive demand for poultry vaccinations. Consuming infected poultry meat poses a threat to human health. It is important that birds are vaccinated. Poultry farms have to contend with the rapid spread of disease and a lack of treatment options. Vaccination becomes mandatory in order to avoid these situations. According to OIE WAHIS databases, there were 22 new cases of bird flu in the world. This rose to 836 new cases in 2020. The total number of cases is 2.79 million. Market drivers include the growing incidence of disease outbreaks among avian birds. Low pathogenic and highly pathogenic influenza were reported in Italy in recent weeks. They were also reported in Russia in October 2021.

Regional Analysis:

Europe held the largest revenue percentage of 32.5% or more in 2021. This is due to a number of key players and growing opposition to antimicrobials in animals. There are also rising concerns about zoonoses. Antimicrobial-resistant has been identified as a public health threat by the World Health Organization. Many public health organizations and veterinary regulatory authorities, including the CVMP, are responsible for implementing the EU’s One Health Action Plan for antimicrobial resistance by deploying policies from the Veterinary Medicines Regulation.

Asia Pacific is projected to grow at a 7.8% CAGR during the forecast period. This is due in part to increased awareness regarding poultry vaccinations and the emergence of more vaccination awareness programs. Some other factors include government initiatives and rapid improvements in animal husbandry.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

The global Poultry Vaccines market is fragmented. The market is characterized by fierce competition because of the presence of both local and global players looking to increase their penetration through different strategic moves such as new product development and Merger & Acquisition, partnerships, as well as distribution channel agreements.

Маrkеt Кеу Рlауеrѕ:

• Ceva
• Zoetis
• Elanco
• Intervet Inc.
• Hester Biosciences Limited
• Vaxxinova International BV
• Venkys India
• Calier
• Other Key Players

For the Poultry Vaccines Market research study, the following years have been considered to estimate the market size: